微信小陈
微信小章| 产品名称： | Mycoplasma pneumoniae Somerson et al. |
|---|---|
| 商品货号： | TS139959 |
| Strain Designations： | M129-B170 |
| Application： | Respiratory research |
| Isolation： | Avirulent mutant, derived from ATCC 29342 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 988: Spiroplasma medium SP-4 |
| Growth Conditions： | Max Temperature: 37.0°C Min Temperature: 35.0°C Atmosphere: 5% CO2 |
| Name of Depositor： | WA Clyde |
| References： | Lipman RP, et al. Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains. J. Bacteriol. 100: 1037-1043, 1969. PubMed: 5359607 Lipman RP, Clyde WA Jr.. The interrelationship of virulence, cytadsorption, and peroxide formation in Mycoplasma pneumoniae. Proc. Soc. Exp. Biol. Med. 131: 1163-1167, 1969. PubMed: 5811969 Collier AM, et al. Biologic effects of Mycoplasma pneumoniae and other mycoplasmas from man on hamster tracheal organ culture. Proc. Soc. Exp. Biol. Med. 132: 1153-1158, 1969. PubMed: 5391202 |